Intact Investment Management Cut Its Stantec (STN) Position; Chf Solutions (CHFS) SI Decreased By 9.24%

Intact Investment Management Inc decreased Stantec Inc (STN) stake by 52.56% reported in 2018Q4 SEC filing. Intact Investment Management Inc sold 149,900 shares as Stantec Inc (STN)’s stock declined 0.33%. The Intact Investment Management Inc holds 135,300 shares with $4.03M value, down from 285,200 last quarter. Stantec Inc now has $2.72 billion valuation. The stock decreased 0.57% or $0.14 during the last trading session, reaching $24.35. About 4,874 shares traded. Stantec Inc. (NYSE:STN) has declined 4.28% since April 17, 2018 and is downtrending. It has underperformed by 8.65% the S&P500. Some Historical STN News: 26/04/2018 – Stantec Signs Letter Of Intent To Acquire Cegertec; 19/03/2018 – Stantec Signs Letter Of Intent To Acquire Norwest; 11/05/2018 – Stantec 2018 Annual Meeting of Shareholders Results; 27/03/2018 – Stantec Acquires ESI Consulting; 19/03/2018 – STANTEC SIGNS LETTER OF INTENT TO BUY NORWEST; 08/05/2018 – Stantec Selected to Design Hampstead Bypass and US 17 lmprovements in Hampstead in New Hanover and Pender Counties, North Carolina; 27/03/2018 – STANTEC BUYS ESI CONSULTING; 10/05/2018 – Stantec 1Q EBITDA C$90.3M; 26/04/2018 – STANTEC SIGNS LETTER OF INTENT TO BUY CEGERTEC; 10/05/2018 – Stantec 1Q Net C$36.8M

Chf Solutions Inc (NASDAQ:CHFS) had a decrease of 9.24% in short interest. CHFS’s SI was 91,300 shares in April as released by FINRA. Its down 9.24% from 100,600 shares previously. With 12,800 avg volume, 7 days are for Chf Solutions Inc (NASDAQ:CHFS)’s short sellers to cover CHFS’s short positions. The SI to Chf Solutions Inc’s float is 23.24%. The stock decreased 5.37% or $0.2217 during the last trading session, reaching $3.9083. About 103,530 shares traded. CHF Solutions, Inc. (NASDAQ:CHFS) has declined 79.79% since April 17, 2018 and is downtrending. It has underperformed by 84.16% the S&P500.

CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company has market cap of $8.09 million. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It currently has negative earnings. The firm was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017.

More notable recent CHF Solutions, Inc. (NASDAQ:CHFS) news were published by: Nasdaq.com which released: “CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis – Nasdaq” on April 16, 2019, also Globenewswire.com with their article: “CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute – GlobeNewswire” published on April 09, 2019, Seekingalpha.com published: “CHF Solutions up 3% on Aquadex patent application – Seeking Alpha” on April 03, 2019. More interesting news about CHF Solutions, Inc. (NASDAQ:CHFS) were released by: Benzinga.com and their article: “30 Stocks Moving In Monday’s Pre-Market Session – Benzinga” published on April 15, 2019 as well as Globenewswire.com‘s news article titled: “CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific Sessions – GlobeNewswire” with publication date: March 28, 2019.

Investors sentiment decreased to 0.75 in 2018 Q4. Its down 0.09, from 0.84 in 2018Q3. It worsened, as 9 investors sold STN shares while 27 reduced holdings. 5 funds opened positions while 22 raised stakes. 73.28 million shares or 1.06% more from 72.51 million shares in 2018Q3 were reported. Fiera has 702,135 shares for 0.07% of their portfolio. National Bank & Trust Of America De stated it has 10,111 shares or 0% of all its holdings. Tobam reported 77,800 shares. Fil, Bermuda-based fund reported 1.18M shares. 34,951 are owned by Mirae Asset Investments Co Ltd. Pnc Finance Gp Incorporated reported 0% in Stantec Inc. (NYSE:STN). Shell Asset Mgmt stated it has 0.01% of its portfolio in Stantec Inc. (NYSE:STN). Fmr Lc reported 0% of its portfolio in Stantec Inc. (NYSE:STN). Addenda reported 207,073 shares or 0.4% of all its holdings. Cibc Asset Incorporated reported 62,509 shares stake. Switzerland-based Credit Suisse Ag has invested 0% in Stantec Inc. (NYSE:STN). Jupiter Asset Management reported 432,081 shares. Cibc World Markets Inc invested 0.02% of its portfolio in Stantec Inc. (NYSE:STN). 1832 Asset Limited Partnership has 0% invested in Stantec Inc. (NYSE:STN) for 3,858 shares. California-based Franklin Res has invested 0.06% in Stantec Inc. (NYSE:STN).

Intact Investment Management Inc increased Southern Co (NYSE:SO) stake by 99,200 shares to 169,100 valued at $7.43M in 2018Q4. It also upped Rogers Communications Inc (NYSE:RCI) stake by 9,200 shares and now owns 784,230 shares. Gran Tierra Energy Inc (NYSEMKT:GTE) was raised too.

Another recent and important Stantec Inc. (NYSE:STN) news was published by Seekingalpha.com which published an article titled: “Stantec Inc. 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” on August 08, 2018.

Analysts await Stantec Inc. (NYSE:STN) to report earnings on May, 9. They expect $0.38 earnings per share, up 15.15% or $0.05 from last year’s $0.33 per share. STN’s profit will be $42.43M for 16.02 P/E if the $0.38 EPS becomes a reality. After $0.30 actual earnings per share reported by Stantec Inc. for the previous quarter, Wall Street now forecasts 26.67% EPS growth.